| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_944078e593116d638eee0d91ff2b8d2d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C317-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C317-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-10 |
| filingDate |
2016-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_260b61544bd70af39503c189e9283e60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0f5df127a76858c8aeec2d4b9b97ed1 |
| publicationDate |
2016-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016193461-A1 |
| titleOfInvention |
ROR GAMMA (RORγ) MODULATORS |
| abstract |
The present invention relates to novel compounds according to Formula (I) or a pharmaceutically acceptable salt thereof. The compounds can be used as inhibitors of RORγ and are useful for the treatment of RORγ mediated diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11453644-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018011746-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018235813-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10988445-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10526286-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018011747-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11034654-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109593068-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10011566-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109593068-B |
| priorityDate |
2015-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |